GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

GLAXO

株式のランク #3658
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
株価
$27.24
時価総額
$4.61B
変化(1日)
-1.10%
変化(1年)
-13.10%
国
IN
取引 GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

カテゴリー

Healthcare
GlaxoSmithKline Pharmaceuticals Limited(GLAXO)のP/B比率
October 2026 時点のP/B比率 TTM: 18.70
GlaxoSmithKline Pharmaceuticals Limited の最新の財務報告および株価によると、現在のP/B比率(TTM)は 18.70 です。2024 年末時点でのP/B比率は 18.93 でした。
GlaxoSmithKline Pharmaceuticals Limited の P/B 比率の履歴(2004 ~ 2026)
各年末時点のP/B比率
年 P/B比率 変化
2026 (TTM) 18.70 -23.00%
2025 24.29 28.30%
2024 18.93 46.87%
2023 12.89 21.54%
2022 10.60 -35.77%
2021 16.51 41.12%
2020 11.70 13.72%
2019 10.29 18.79%
2018 8.66 -25.23%
2017 11.58 -39.20%
2016 19.05 60.47%
2015 11.87 -7.01%
2013 12.77 39.51%
2012 9.15 7.51%
2011 8.51 -16.10%
2010 10.15 32.71%
2009 7.64 23.58%
2008 6.19 -1.82%
2007 6.30 -22.76%
2006 8.16 -19.22%
2005 10.10 38.74%
2004 7.28 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
31.9092 70.60%
US
7.3138 -60.90%
US
-84.6033 -552.32%
US
8.6873 -53.56%
US
8.4776 -54.68%
CH